These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23913854)

  • 1. Immunotherapy with injectable hydrogels to treat obstructive nephropathy.
    Soranno DE; Lu HD; Weber HM; Rai R; Burdick JA
    J Biomed Mater Res A; 2014 Jul; 102(7):2173-80. PubMed ID: 23913854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local immunotherapy via delivery of interleukin-10 and transforming growth factor β antagonist for treatment of chronic kidney disease.
    Rodell CB; Rai R; Faubel S; Burdick JA; Soranno DE
    J Control Release; 2015 May; 206():131-9. PubMed ID: 25804871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice.
    Soranno DE; Rodell CB; Altmann C; Duplantis J; Andres-Hernando A; Burdick JA; Faubel S
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F362-72. PubMed ID: 26962109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice.
    Lange-Sperandio B; Cachat F; Thornhill BA; Chevalier RL
    Kidney Int; 2002 Feb; 61(2):516-24. PubMed ID: 11849391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of Gadd45β ameliorates the inflammation and renal fibrosis caused by unilateral ureteral obstruction.
    Moon SJ; Kim JH; Choi YK; Lee CH; Hwang JH
    J Cell Mol Med; 2020 Aug; 24(15):8814-8825. PubMed ID: 32570293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy.
    Gao X; Mae H; Ayabe N; Takai T; Oshima K; Hattori M; Ueki T; Fujimoto J; Tanizawa T
    Kidney Int; 2002 Oct; 62(4):1238-48. PubMed ID: 12234294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-assembling peptide hydrogel-based drug co-delivery platform to improve tissue repair after ischemia-reperfusion injury.
    Liu S; Zhao M; Zhou Y; Li L; Wang C; Yuan Y; Li L; Liao G; Bresette W; Chen Y; Cheng J; Lu Y; Liu J
    Acta Biomater; 2020 Feb; 103():102-114. PubMed ID: 31843715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable extracellular vesicle-released self-assembling peptide nanofiber hydrogel as an enhanced cell-free therapy for tissue regeneration.
    Zhou Y; Liu S; Zhao M; Wang C; Li L; Yuan Y; Li L; Liao G; Bresette W; Zhang J; Chen Y; Cheng J; Lu Y; Liu J
    J Control Release; 2019 Dec; 316():93-104. PubMed ID: 31704110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
    Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
    Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy.
    Yamagishi H; Yokoo T; Imasawa T; Mitarai T; Kawamura T; Utsunomiya Y
    J Immunol; 2001 Jan; 166(1):609-16. PubMed ID: 11123344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Therapeutics: Can Hydrogels Work to Treat Kidney Disease?
    Soranno DE; Rodell CB
    Nephron; 2023; 147(12):769-773. PubMed ID: 37490877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
    Jia L; Ma X; Gui B; Ge H; Wang L; Ou Y; Tian L; Chen Z; Duan Z; Han J; Fu R
    PLoS One; 2015; 10(2):e0117757. PubMed ID: 25679376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hirudin improves renal interstitial fibrosis by reducing renal tubule injury and inflammation in unilateral ureteral obstruction (UUO) mice.
    Xie Y; Lan F; Zhao J; Shi W
    Int Immunopharmacol; 2020 Apr; 81():106249. PubMed ID: 32066115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained delivery of IL-10 by self-assembling peptide hydrogel to reprogram macrophages and promote diabetic alveolar bone defect healing.
    Wang C; Li T; Zeng X; Wu L; Gao M; Tong N; Duan P; Liu J
    Dent Mater; 2023 Apr; 39(4):418-429. PubMed ID: 36931990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation.
    Hassan NME; Said E; Shehatou GSG
    Life Sci; 2021 May; 272():119241. PubMed ID: 33600861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats.
    Wang FM; Yang YJ; Ma LL; Tian XJ; He YQ
    Nephrology (Carlton); 2014 Sep; 19(9):542-51. PubMed ID: 24754438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation.
    Zheng M; Cai J; Liu Z; Shu S; Wang Y; Tang C; Dong Z
    J Cell Mol Med; 2019 Jun; 23(6):3995-4004. PubMed ID: 30993884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-release of therapeutic microRNA via a host-guest supramolecular hydrogel to locally alleviate renal interstitial fibrosis.
    Xu Y; Niu Y; Wu B; Cao X; Gong T; Zhang ZR; Fu Y
    Biomaterials; 2021 Aug; 275():120902. PubMed ID: 34087588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy.
    Lange-Sperandio B; Forbes MS; Thornhill B; Okusa MD; Linden J; Chevalier RL
    Nephron Exp Nephrol; 2005; 100(3):e113-23. PubMed ID: 15824514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.